Tag Archives: Boris Peaker

Cowen & Co. Keeps Their Buy Rating on Urogen Pharma Ltd (URGN)

In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Urogen Pharma Ltd (NASDAQ: URGN). The company’s shares opened today at $46. According to TipRanks.com, Peaker is a 5-star analyst with an average return

Cowen & Co. Remains a Buy on Surface Oncology Inc (SURF)

In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Surface Oncology Inc (NASDAQ: SURF). The company’s shares opened today at $9.69, close to its 52-week low of $9.07. According to TipRanks.com, Peaker is

Cowen & Co. Keeps Their Hold Rating on Jounce Therapeutics Inc (JNCE)

In a report released today, Boris Peaker from Cowen & Co. maintained a Hold rating on Jounce Therapeutics Inc (NASDAQ: JNCE). The company’s shares opened today at $7.84, close to its 52-week low of $6.56. According to TipRanks.com, Peaker is

Analysts Offer Insights on Healthcare Companies: Celldex (NASDAQ: CLDX), Sangamo Biosciences (NASDAQ: SGMO) and Endo International (NASDAQ: ENDP)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Celldex (NASDAQ:CLDX), Sangamo Biosciences (NASDAQ:SGMO) and Endo International (NASDAQ:ENDP). Celldex (CLDX) In a report released today, Boris Peaker from Cowen & Co. maintained

Analysts Are Bullish on Top Healthcare Stocks: MacroGenics (MGNX), SAGE Therapeutics (SAGE)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MacroGenics (NASDAQ:MGNX) and SAGE Therapeutics (NASDAQ:SAGE) with bullish sentiments. MacroGenics (MGNX) In a report released today, Boris Peaker from Cowen & Co.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ironwood Pharma (NASDAQ: IRWD) and Ovid Therapeutics Inc (NASDAQ: OVID)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ironwood Pharma (NASDAQ:IRWD) and Ovid Therapeutics Inc (NASDAQ:OVID). Ironwood Pharma (IRWD) Cowen & Co. analyst Boris Peaker maintained a Hold rating on Ironwood Pharma today